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Abstract
Background: The pathogenic role of brain derived neurotrophic factor (BDNF) in the incisional
pain is poorly understood. The present study explores the role of the BDNF in the incision-induced
pain hypersensitivity.
Methods: A longitudinal incision was made in one plantar hind paw of isoflurane-anesthetized rats.
Dorsal root ganglias (DRG) and spinal cords were removed at various postoperative times (1–72
h). Expression pattern of BDNF was determined by immunohistochemistry and double-labeling
immunofluorescence. Lidocaine-induced blockade of sciatic nerve function was used to determine
the importance of afferent nerve activity on BDNF expression in the DRG and spinal cord after
incision. BDNF antibody was administered intrathecally (IT) or intraperitoneal (IP) to modulate the
spinal BDNF or peripheral BDNF after incision.
Results: After hind-paw incision, the BDNF was upregulated in the ipsilateral lumbar DRG and
spinal cord whereas thoracic BDNF remained unchanged in response to incision. The upregulated
BDNF was mainly expressed in the large-sized neurons in DRG and the neurons and the primary
nerve terminals in the spinal cord. Sciatic nerve blockade prevented the increase of BDNF in the
DRG and spinal cord. IT injection of BDNF antibody greatly inhibited the mechanical allodynia
induced by incision whereas IP administration had only marginal effect.
Conclusion: The present study showed that incision induced the segmental upregulation of BDNF
in the DRG and spinal cord through somatic afferent nerve transmission, and the upregulated
BDNF contributed to the pain hypersensitivity induced by surgical incision.
Background
Brain derived neurotrophic factor (BDNF) is a 12.4-kDa
basic protein initially isolated from pig brain and widely
expressed in the peripheral and central nervous system. In
the dorsal root ganglia (DRG), BDNF is expressed in the
small- and medium-sized neurons and anterogradely
transported to the central terminals of the spinal cord
where BDNF is located in large dense-cored vesicles in ter-
minals of primary afferent fibers in groups I and II glomer-
uli [1,2]. Numerous studies show that BDNF is a
modulator of pain in the inflammatory and neuropathic
pain. First, in the formalin and carrageenan-induced pain
models, BDNF was upregulated in the DRG and spinal
cord and sequestering the upregulated BDNF reduced the
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pain hypersensitivity [3,4]. Second, in another inflamma-
tory pain model induced by complete Freund's adjuvant
(CFA) hind paw injection, BDNF was also increased in the
spinal cord, and pretreatment with anti-BDNF antiserum
abolished the increased number of neurons as well as the
pain hypersensitivity after CFA injection [5]. The upregu-
lation of BDNF in the DRG was mediated by nerve growth
factor (NGF)-dependent mechanism [6,7]. On the other
hand, BDNF is also increased in the medium- and large-
sized DRG neurons and their central terminals as well as
the activated microglia in spinal cord in the neuropathic
pain model in the rat and mouse, and delivery of BDNF
antibodies reduced pain-related behavior [8,9]. However,
it remains to be ascertained whether BDNF is also
involved in another type of pain, post-operative pain.
Post-operative pain, a unique and common form of acute
pain, could induce the rest pain and incident pain (a
mechanically evoked pain) [10]. Growing evidence dem-
onstrated that non-NMDA receptors were linked to the
pain hypersensitivity induced by surgical incision whereas
NMDA receptors were believed to play critical roles in
other types of pathological pain [11-13]. These reports
indicate that there may be distinct neurochemical changes
in the spinal cord between incision-induced pain and
other types of pathological pain. It is still poorly under-
stood the pathogenic role of BDNF in the DRG and spinal
cord in the incision-evoke pain hypersensitivity. In this
regard, a previous post-operative study showed that
another neurotrophic factor, NGF contributed to the inci-
sion-evoked guarding pain behavior [14]. Given that the
increased NGF in response to peripheral inflammation
could induce the upregulation of BDNF in the DRG and
spinal cord, which subsequently phosphorylated the
downstream signals including NMDA receptor subunit
NR1, tropomyosine receptor kinase B (TrkB) and extracel-
lular regulating kinase (ERK) [15,16], it is possible that
BDNF is also associated with the incision-evoked pain
hypersensitivity. Supporting this hypothesis, our recent
study showed that surgical incision also activated glial
cells and upregulated interleukin-1 beta (IL-1β), a proin-
flammatory cytokine regulated by ERK [17]. Thus, it is
rational to postulate that BDNF is associated with the inci-
sion-evoked pain hypersensitivity. The present study is
thus aimed to investigate the role of BDNF in the pain
hypersensitivity induced by incision.
Results
Segmental upregulation of BDNF in the spinal cord after 
hind-paw incision
At 1 hour after hind-paw surgical incision, the expression
of BDNF was increased dramatically in the ipsilateral dor-
sal horn of the lumbar spinal cord as compared with that
in the contralateral side (p < 0.05, Figure 1A and Table 1).
Increased BDNF level reached the peak level at 6 hours
after incision when the BDNF protein level was about the
2.5 folds of that in contralateral side (p < 0.05, Figure 1B
and Table 1). The elevated BDNF-IR positive staining,
which appeared to be the axon fibers and neurons, were
found in the superficial dorsal horn (lamina I and II). In
the deep dorsal horn (lamina III and IV), considerable
increased intensity of BDNF-IR was also observed in the
neurons (Table 1). Mild upregulation of BDNF was
observed at 1 day following surgery (p < 0.05, Figure 1C,
Table 1). At 3 days after incision, the expression of BDNF
(Figure 1D) was comparable with the sham-operated rats
(Figure 1E) (Table 1).
To further explore whether incision-induced BDNF upreg-
ulation is mediated by a specific effect in the related seg-
ments or unspecific effect in the whole spinal cord, the
expression pattern of the BDNF in the thoracic segments
was examined. There was no significant alteration for
BDNF-IR in the thoracic segments after surgical incision as
compared with the sham-operation (Figure 1F and 1G)
(Table 1) suggesting that the incision induced segmental
BDNF upregulation in the spinal cord.
Localization of BDNF in the spinal cord following surgical 
incision
In attempt to confirm the localization of the upregulated
BDNF, double immunofluorescence was performed. As
shown in Figure 2, the upregulated BDNF was mainly
localized in the neurons and the primary nerve terminals
in the superficial layers and the deep layers of the dorsal
horns (Figure 2B). Scarce BDNF was expressed in the
GFAP-IR cells (Figure 2C), or OX-42-IR cells (Figure 2D).
These data suggest that the neurons and nerve terminals
be the mainly source of the upregulated BDNF.
Increased BDNF expression in the DRG after hind-paw 
incision
Similar to the expression pattern in the spinal cord in
response to the spinal cord, the BDNF-expressing cells
(red) in the DRG were increased 117% at 1 hour (Figure
3B) and 163% at 6 hour (Figure 3C) in the ipsilateral DRG
following incision as compared with those in the contral-
ateral DRG (Figure 3A)(p < 0.05, Table 2). The increased
BDNF expressing neurons sustained more than 1 day fol-
lowing incision (Table 2). At 3 days after surgery, the
number of BDNF-IR cells in the DRG (Figure 3D) in the
ipsilateral side of incision went back to the basal level
(Table 2). Quantitative analysis showed that the increased
BDNF-IR was mainly expressed in the large-sized neurons
in ipsilateral DRG, However, the percentage of BDNF-IR
in the small-sized neurons was decreased dramatically
after surgical incision (Table 3). This suggests that surgical
incision induce the shift of BDNF expression from small-
sized neurons to large-sized neurons in DRG.Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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Segmental upregulation of spinal BDNF after hind-paw incision Figure 1
Segmental upregulation of spinal BDNF after hind-paw incision. Representative photomicrographs of BDNF-IR den-
sity in the lumbar (L4–L5) (Figure 1A-E) and thoracic segments (T1–T2) (Figure 1F and G) of the spinal cord in the rats after 
hind-paw incision. In the lumbar segments, the increased BDNF expression in the dorsal horns of the ipsilateral spinal cord was 
observed at 1 hour (Figure 1A), 6 hours (Figure 1B) and 1 day (Figure 1C) after incision. At 3 days after incision, BDNF expres-
sion (Figure 1D) was comparable to the sham-operated control (Figure 1E). No significant difference of BDNF expression in 
thoracic segments between the control (Figure 1F) and 6 hour after incision (Figure 1G). Bar = 150 μm.Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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To further determine whether the upregulation of BDNF
was also from glial cells, double labeling of BDNF either
with S-100 or GFAP, both of which are the markers for sat-
ellite cells and Schwann cells in DRG, were performed. As
shown in Figure 4, a few BDNF-IR cells were also co-local-
ized with satellite cells surrounding the neurons indicat-
ing that surgical incision activates glia cells in DRG to
release BDNF.
Involvement of afferent nerve transmission in the incision-
mediated BDNF upregulation
To further investigate the role of nerve transmission in the
increased BDNF after hind-paw incision, sciatic nerve
Table 1: The OD of BDNF-IR in the spinal cord dorsal horns of lumbar (L4–L5) and thoracic (T1–T2) 
OD of BDNF-IR L4–L5 Spinal Cord T1–T2 Spinal Cord
Sham 1h 6h 1d 3d Sham 6h
Lamina I-II Contra 0.19 ± 0.03 0.23 ± 0.04 0.22 ± 0.05 0.25 ± 0.04 0.21 ± 0.03 0.18 ± 0.05 0.20 ± 0.04
Ipsi 0.20 ± 0.04 0.43 ± 0.06*# 0.58 ± 0.04*# 0.46 ± 0.05*# 0.20 ± 0.04 0.20 ± 0.03 0.24 ± 0.05
Lamina III-IV Contra 0.12 ± 0.07 0.15 ± 0.02 0.16 ± 0.09 0.14 ± 0.03 0.13 ± 0.03 0.17 ± 0.04 0.16 ± 0.03
Ipsi 0.11 ± 0.04 0.35 ± 0.01*# 0.40 ± 0.04*# 0.37 ± 0.02*# 0.15 ± 0.05 0.14 ± 0.06 0.18 ± 0.01
segments after hind-paw incision
* p < 0.05 vs contralateral side, #p < 0.05 vs sham-operated group
Localization of BDNF in the spinal cord after hind-paw incision Figure 2
Localization of BDNF in the spinal cord after hind-paw incision. Representative photomicrographs of the double 
immunofluorescence of BDNF (red, Figure 2A) with NeuN-IR (marker of neuron, green in Figure 2B), GFAP-IR (marker of 
astrocyte, green in Figure 2C) or OX-42 (marker of microglia, green in Figure 2D). Note that abundant BDNF expressing cells 
were also expressed in the neurons but scarcely expressed in the astrocytes or microglia. Bar = 150 μm.Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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block was performed by lidocaine injection just before
incision. Successful block was confirmed by the nocicep-
tive testing. Blocking the sensory impulses by lidocaine
dramatically reduced BDNF protein level in spinal cord
(Figure 5A and 5B) and DRG (Data not shown) at 1 h after
incision at the ipsilateral side of incision (p < 0.05, lido-
caine block vs saline injection, Table 4)
Neutralization of the spinal BDNF attenuated incision-
induced allodynia
The upregulation of BDNF in the DRG and spinal cord fol-
lowing incision suggests that BDNF may be involved in
the incisional pain. Mechanical allodynia is the typical
feature of human surgical wounds as well as the rat model
of incisional pain in which allodynia sustained more than
1 day. To explore the role of BDNF in the development of
mechanical allodynia induced by surgical incision, IP
administration or IT injection of anti-BNDF antibody
were performed before surgical incision. As shown in Fig-
ure 6A, pretreatment of anti-BDNF antibody by IT injec-
tion greatly inhibited the mechanical allodynia induced
by incision. In a sharp contrast, IP injection of anti-BDNF
antibody had only marginal effect on the mechanical allo-
dynia induced by incision (Figure 6B).
Discussion
There are several interesting findings in the present study
that sought to identify the role of BDNF in the incisional
pain. First, hind-paw incision induced transient activation
of BDNF expression, mainly localized in the nerve termi-
nals and neurons in the lumbar DRG and spinal cord; Sec-
ond, the increased BDNF expression was changed to large-
sized neurons from the small-sized neurons in the DRG in
response to surgical incision; Third, sciatic nerve block by
local anesthetic can prevent the upregulated BDNF in the
DRG and spinal cord; Finally, IT administration, but not
IP administration of anti-BDNF antibody dramatically
reduced the mechanical allodynia developed by the inci-
sion.
Like inflammatory pain and neuropathic pain, incisional
pain also induced the upregulation of BDNF in the DRG
and spinal cord in the present study. However, the expres-
sion pattern of BDNF in the incisional pain was distinct
from those in the inflammatory pain and neuropathic
pain. In neuropathic pain, the increased BDNF in the spi-
nal cord was mainly expressed in the activated microglia
[18]. On the other hand, in the CFA-induced inflamma-
tory pain model, BDNF expression was considerably
increased in the small- and median-sized neurons in the
Increased BDNF expression in the DRG after hind-paw inci- sion Figure 3
Increased BDNF expression in the DRG after hind-
paw incision. Representative photomicrographs showing 
immunostaining of BDNF (red) in the ipsilateral DRG after 
hind-paw incision (Figure 3B-D) or the control (Figure 3A). 
The nuclei were stained by Hoechest (blue). Increased BDNF 
expressing neurons were observed at 1 hour after incision 
(Figure 3B) and sustained 1 day after incision (Figure 3C). 
The expression of BDNF at 3 days after incision (Figure 3D) 
went back to the basal level. Bar = 40 μm.
Table 2: Percentage of BDNF-IR neurons in the DRG (L4–L5) after hind-paw incision
Percentage of 
BDNF-IR neurons
L4-L5 DRG
Sham 1h 6h 1d 3d
Contra 12.8 ± 1.8 14.5 ± 1.4 13.4 ± 1.6 14.6 ± 2.4 14.3 ± 2.1
Ipsi 13.4 ± 2.1 31.5 ± 3.7*# 35.3 ± 4.4*# 34.7 ± 3.6*# 16.1 ± 2.5
* p < 0.05 vs contralateral side, #p < 0.05 vs sham-operated group
Table 3: Percentage of different size BDNF-IR neurons in total 
BDNF-IR neurons in DRG at 6 hrs after hind-paw incision
BDNF-IR neurons size
small medium large
Contra 0.63 ± 0.12 0.30 ± 0.08 0.07 ± 0.01
Ipsi 0.35 ± 0.10*# 0.36 ± 009 0.28 ± 0.11*#
Sham 0.66 ± 0.13 0.26 ± 0.07 0.08 ± 0.03
*p < 0.05 vs contralateral side, #p < 0.05 vs sham-operated group.
DRG neuron size: small: < 20 μm, medium: 20–40 μm; large: > 40 μmMolecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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DRG and the axon fibers in the dorsal horns [19]. In the
present study, surgical incision induced the activation of
BDNF in the large-sized neurons in DRG and the axon fib-
ers and neurons in the dorsal horns indicating a unique
BDNF expression in response to surgical incision. The dis-
tinct expression pattern of BDNF in these three types of
pain strongly indicated that there might be different roles
of BDNF in these three types of pain and the incisional
pain has a unique mechanism as compared with the other
two types of pathological pain. More interestingly, the ele-
vated BDNF level in DRG was also localized in the large-
sized neurons although BDNF is normally expressed in
the small- and medium-sized neurons. Given that the cen-
tral fibers of large-sized neurons in DRG mainly project to
the deep layers of spinal cord which are closely related to
mechanical allodynia, the phenotypic changes of the ele-
vated BDNF in the present study strongly suggest that the
activated BDNF is involved in the development of
mechanical allodynia after surgical incision.
In the present study, IT injection of BDNF antibody atten-
uated the mechanical allodynia after incision strongly
suggesting that BDNF was implicated in the incision-
evoked mechanical allodynia. However, it remains elusive
the underlying mechanism that BDNF contributes to the
incision-evoked pain hypersensitivity. Ample evidence
Localization of BDNF in the DRG after hind-paw incision Figure 4
Localization of BDNF in the DRG after hind-paw incision. Representative double immunofluorescence labeling of 
BDNF (red) with S-100 (Green) (Figure 4A) and GFAP (green) (Figure 4B) in the ipsilateral DRG after hind-paw incision for 6 
hours; arrow indicate double labeling. Bar = 50 μm.
Incision-induced BDNF upregulation through nerve transmission Figure 5
Incision-induced BDNF upregulation through nerve transmission. Representative photomicrographs of BDNF-IR in 
the ipsilateral lumbar spinal cord pretreated by saline (Figure 5A) or lidocaine (Figure 5B) sciatic nerve block followed by hind-
paw incision. Bar = 150 μm.Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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demonstrated that incision-evoked pain hypersensitivity
was mainly mediated by AMPA/kainite-dependent mech-
anisms, but not NMDA receptor-dependent mechanism.
This is because the AMPA antagonist but not NMDA
receptor antagonist can reverse the incision-evoked pain
hypersensitivity [11-13]. However, the data from mice
and rat in vitro spinal cord preparation showed that BDNF
led to hyperalgesia via an NMDA-mediated mechanism
after peripheral inflammation [3,20]. Together with previ-
ous studies, the present study suggests that BDNF modu-
late the incision-evoked pain hypersensitivity through
non-NMDA receptors such as TrkB or ERK. In this regard,
compelling evidence showed that intraspinal injection of
BDNF could phosphoryate ERK in the spinal cords, which
subsequently activate the downstream signals including
the pain-related neurotransmitters [21] or the related
inflammatory mediator, IL-1β[17].
It has been reported that NGF contributed to the neuro-
pathic pain and inflammatory pain, and was also associ-
ated with incision-evoked pain hypersensitivity [14]. The
increase of NGF in the subcutaneous tissue after hind-paw
incision was coincided with the pain-related behavior,
and systemic anti-NGF treatment could reverse the inci-
sion-evoked guarding pain, but not mechanical allodynia
[14]. In spite of the fact that activation of BDNF was one
way that NGF contributed to inflammatory pain [2,22],
BDNF might play the differential roles in the incision-
evoked pain hypersensitivity as compared with NGF. In
the present study, the fact that IT injection, but not sys-
temic treatment of anti-BDNF antibody reduced the inci-
sion-evoked mechanical allodynia strongly indicated that
BDNF might be involved in the incision-evoked mechan-
ical allodynia whereas NGF be associated with spontane-
ous-like pain after incision.
Considerable evidence shows that inflammatory media-
tors in the spinal cord are activated segmentally in
response to surgical incision. It has been reported that
bilateral hind paw incision induce mild increase of
cyclooxygenas 2 (COX-2) in the lumbar spinal cord but
not cervical segments [23,24]. Our recent study also
showed that surgical incision induced the segmental
upregulation of IL-1β in the spinal cord [17]. In the
present study, incision also induced the increase of BDNF
level in the ipsilateral lumbar segments but not that in the
contralateral side or thoracic spinal cord suggesting the
expression pattern of BDNF level in the spinal cord was
similar to that of COX-2 or the cytokines. However, unlike
the activated inflammatory mediators which were not
affected by the sciatic nerve block [23,24], the increased
BDNF in the DRG or spinal cord could be totally pre-
vented by the sciatic nerve block. These strongly indicate
that the underlying mechanisms that incision-mediated
the activation of inflammatory mediators and incision-
mediated BDNF upregulation in the spinal cord are differ-
ent. The rapid increase of BDNF in the DRG and spinal
cord also rules out the possibility of the retrogradely trans-
port of BDNF from the local injured tissue [25]. The fact
that pretreatment of lidocaine completely prevented the
upregulation of BDNF after incision indicated that the
increased BDNF is through by nerve afferent transmission.
In this regard, considerable evidence shows that neuronal
depolarization induced by KCL or electrical stimulation of
C fibers can induce the sustained increase of BDNF expres-
sion in cerebellar granule or sensory neurons [26-28]. In
the present study, the increased BDNF is likely from the de
nono synthesis in the large-sized neurons in DRG and
novel induction in the spinal cord due to the activated
burst of firing from the sensitized nerve endings in the
injured tissue. The upregulated BNDF, in turn, may acti-
vate downstream signaling and contribute to the develop-
ment of mechanical allodynia following incision.
In the present study, the IT injection but not IP injection
of anti-BDNF antibody substantially inhibited incision-
evoked mechanical allodynia suggesting that the spinal
BDNF may play more important role for the incision-
evoked pain hypersensitivity. Thus, blocking the upregu-
lated spinal BDNF may be a novel potential therapeutic
approach to treat post-operative pain. It has been well
known that alleviation of the post-operative pain, on the
other hand, can reduce the anxiety and provide subjective
comfort, and should also blunt the autonomic and
somatic reflex response and thus restore organ functions
and enable mobilization and food intake, thereby helping
to improve the outcome. Multimodal analgesia has been
suggested to treat post-operative pain in which combina-
tion of different modalities, working at different pain
mechanisms and reduce the side effect. In this regard, the
Table 4: Effect of sciatic nerve block on BDNF-IR expression at 1 h after incision
OD of BDNF-IR in the dorsal horn Percentage of BDNF-IR neurons
Sham Saline Lidocaine Sham Saline Lidocaine
Contra 0.19 ± 0.03 0.25 ± 0.04 0.24 ± 0.05 12.8 ± 1.8 14.3 ± 1.9 14.2 ± 1.5
Ipsi 0.20 ± 0.04 0.46 ± 0.09*# 0.18 ± 0.04 13.4 ± 2.1 33.2 ± 4.6*# 13.6 ± 0.8
*p < 0.05 vs contralateral side, #p < 0.05 vs sham-operated group, † p < 0.05 vs saline injectionMolecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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Sequestering spinal BDNF attenuates incision-induced allodynia Figure 6
Sequestering spinal BDNF attenuates incision-induced allodynia. Effect of anti-BDNF antibody with IT injection (Fig-
ure 6A) or IP administration (Figure 6B) on mechanical withdrawal thresholds (g) after hind-paw incision. Single anti-BDNF 
antibody IT or IP injection or the saline treatment was performed 1 hour before hind-paw incision. Six to eight rats were used 
in each group. A, IT injection of anti-BDNF antibody dramatically inhibited the allodynia after hind-paw incision (p < 0.01, two-
way repeated measure ANOVA). B, Significant difference was present between IP administration of anti-BDNF antibody (10 
mg/kg) and saline treatment. *p < 0.05, group with anti-BDNF IP administration vs control by saline injection; **p < 0.01, group 
with anti-BDNF IT treatment vs the control by saline injection; † p < 0.01, groups after hind-paw incision vs sham-operated 
control.Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
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opioids, paracetamol, NSAIDs, and COX-2 inhibitors are
widely used as the pharmaceutical interventions to treat
pain [29]. In the present study, the mechanism of inci-
sion-mediated BDNF may be different from that of upreg-
ulated COX-2 or cytokine induced by incision. It still
remains to be determined whether BDNF antagonist (or
inhibitor) can interact with other analgesia or not. How-
ever, the fact that neutralizing the increased BDNF
induced by incision can reduce the mechanical allodynia
following incision strongly suggest that inhibiting BDNF
may be a new approach in the multimodal analgesia to
treat post-operative pain.
Conclusion
The present study demonstrated that incision induced the
segmental upregulation of BDNF in the DRGs and spinal
cords through afferent nerve transmission. The expression
pattern of BDNF was distinct from those in the inflamma-
tory pain and neuropathic pain suggesting that BDNF
have a differential role in the incision-evoked pain hyper-
sensitivity with neuropathic pain and inflammatory pain.
IT injection of anti-BDNF antibody, but not systemic
administration of anti-BDNF antibody dramatically
reduced the developed mechanical allodynia following
incision indicating that spinal BDNF play an important
role in the incision-evoked mechanical allodynia. Thus,
inhibition of the spinal BDNF may be a new approach to
treat post-operative pain.
Materials and Methods
Animals
The study was carried out on male Wistar rats (150–250 g)
obtained from Central South University Animal Services
(Changsha, China). The experimental protocol was
approved by the Animal Care and Use Committee of Cen-
tral South University and conformed to the National Insti-
tutes of Health Guide for the Care and Use of Laboratory
Animals. All efforts were made to minimize the number of
rats used and their suffering.
Surgical preparation and groups
Animals were briefly anesthetized with 1.5% isoflurane in
oxygen, and an incision was made in one hind paw as
described previously [10]. Using sterile technique, a 1-cm
long longitudinal incision was made into the plantar skin
with a no. 11 scalpel blade, starting 0.5 cm from the edge
of the heel. The plantaris muscle was elevated and incised
longitudinally (0.5 cm) with the blade. The skin was
closed with 4-0 nylon sutures using an everted mattress
pattern, and a topical triple antibiotic ointment was
applied to the plantar hind paw. For immunohistochem-
istry and double labeling immunofluorescence, the exper-
imental rats were randomly divided and sacrificed by 1
hour, 6 hours, 1 day and 3 days immediately after nocice-
ptive testing. In an independent group, the rats were
implanted with IT catheter for drug administration. In
another independent group, the experimental rats were
performed for nerve block experiment.
Nociceptive Testing
Mechanical allodynia was assayed using nylon von Frey
filaments according to the "up-down" algorithm
described by Chaplan et al [30]. The nociceptive testing
was performed by two authors who were blind to the
experimental treatment. In these experiments, rats were
placed on wire mesh platforms in clear cylindrical plastic
enclosures of 10 cm diameter. After 20 min of acclima-
tion, fibers of sequentially increasing stiffness were
applied to the center of the plantar surface of the right
hind paw between the first set of foot pads and left in
place 5 s. For incised animals, the fibers were placed
directly on the wound edge. Withdrawal of the hind paw
from the fiber was scored as a response. When no
response was obtained, the next stiffer fiber in the series
was applied to the same paw; if a response was obtained,
a less stiff fiber was next applied. Testing proceeded in this
manner until four fibers had been applied after the first
one causing a withdrawal response allowing the estima-
tion of the mechanical withdrawal threshold.
Intrathecal Catheterization of Rats
Isoflurane-anesthetized rats were implanted with an IT
catheter modified from a method previously described
[31]. After a 6d recovery period, all animals except those
appeared to have sensory or motor abnormalities were
used for experiments. For IT administration, 10 μl of rab-
bit polyclonal anti-BDNF antibody or 10 μl of isotonic
saline was injected through the catheter. In an independ-
ent group, 10 mg/kg anti-BDNF antibody dissolved in the
saline were performed with intraperitoneal (IP) adminis-
tration. The dose of 10 mg/kg was based on our prelimi-
nary study in which three different doses of anti-BDNF
antibody (2.5 mg/kg, 5 mg/kg and 10 mg/kg) were tested
and no statistical significance trend was observed.
Immunohistochemistry and double labeling 
immunofluorescence
Thoracic (T1–T2) and lumbar segments (L4–L5) of the
spinal cord and DRGs from the control and experimental
rats were fixed for 4 hours with 2% paraformaldehyde
after perfusion and cryoprotected by immersion in 20%
sucrose in phosphate buffer (pH 7.4) overnight. Trans-
verse sections of the spinal cord were cut at 30 μm using a
cryostat and mounted on 3-aminopropyl triethoxy-silane-
coated slides, rabbit anti-BDNF antibody (dilution 1:200;
Santa Cruz Biotechnology, USA) were incubated at room
temperature overnight. The secondary reagents used for
localization were biotinylated goat anti-rabbit IgG and
ABC kit (Vector Laboratories, USA). The peroxidase reac-Molecular Pain 2008, 4:27 http://www.molecularpain.com/content/4/1/27
Page 10 of 11
(page number not for citation purposes)
tion was visualized using 3,3'-diaminobenzidine tetrahy-
drochloride (DAB, Sigma, USA) as a peroxidase substrate.
Types of cells expressing BDNF was identified using dou-
ble labeling. The first primary antibodies were polyclonal
rabbit anti-BDNF (dilutions 1:100), and the second pri-
mary antibodies were either mouse anti-OX-42 (for
microglia; dilution 1:2000, Chemicon, USA), anti-GFAP
(for astrocytes in spinal cord and satellite cells in DRG;
dilution 1:2000, Chemicon, USA), anti-NeuN (for neu-
rons; dilution 1:1000, Chemicon, USA) or anti-S-100 (for
satellite and Schwann cells, dilution 1:500, Chemicon,
USA). The respective first and second primary antibodies
were applied to the same sections simultaneously. After
the overnight incubation, sections were then placed in 5
μg/ml Alexa Fluor 488 goat anti-mouse and 594 goat anti-
rabbit IgG1 conjugate (Molecular Probes, Eugene, OR,
USA) for 1 h in the dark at room temperature. After further
washes, the preparations were mounted in Vectashield
mounting medium (Vector Laboratories, USA). Negative
controls were performed routinely by incubating the sec-
tions without either the primary or secondary antibodies.
Nerve Block Experiment
Ten minutes before foot incision, animals were injected
ipsilaterally with local anesthetic using a 25-gauge needle
placed into the sciatic notch. Animals were injected with
lidocaine hydrochloride 1% or normal saline, applying
0.5 ml into each sciatic notch. Sensory nerve block was
confirmed by von Frey filament testing of mechanical
hyperalgesia, which demonstrated an elevation of with-
drawal force threshold to 144 g or greater in rats receiving
local anesthetic block of the sciatic nerve (vs. a hypersen-
sitive 20 g threshold in control incision animals).
Image analysis
HPIAS-1000 image analysis software (Tongji Qingping
Company, PRC) was used for the image analysis. Samples
were viewed under a light microscopy (Motic). Images
were captured using a digital camera (Nikon) attached to
the microscope. Capture parameters were initially estab-
lished and kept unmodified for all images. Five sections
from each specimen and five visual fields for each section
were randomly quantified. In order to define the density
of BDNF immunoreactivity (-IR), we evaluated the rela-
tive optic density (OD) of positive staining. For analysis of
BDNF-IR cells, cells were confirmed positive-labeled if
their density level was over five times background levels
[32]. Under 200 × magnification, the OD value of BDNF-
IR products in the spinal cord and BDNF-IR neurons in
the DRG were measured, and then the mean OD and the
percentage of the positive labeling cells were calculated as
described by a previous study [33]. Profiles of the DRG
neurons were divided, based on size, into small (< 20
μm), medium-sized (20–40 μm), and large (> 40 μm). All
measurements were performed by an author who was
blind with respect to treatments.
Statistical Analysis
Statistics analysis was performed using software SPSS 13.0
(SPSS Inc). The OD of the BDNF-IR products and percent-
age of BDNF-IR neurons were expressed as mean ± SD.
Analysis was accomplished using a one-way analysis of
variance (ANOVA) followed by post hoc Dunnett testing
for the BDNF expression or a two-way analysis of variance
followed by Bonferroni testing for nociceptive testing. A
value of p < 0.05 was considered as significant difference.
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